<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vitalle J</submitter><funding>Instituto de Salud Carlos III</funding><funding>Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Junta de Andalucía</funding><funding>Consejería de Salud, Junta de Andalucía</funding><pagination>e161045</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9536264</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(17)</volume><pubmed_abstract>The immune factors associated with impaired SARS-CoV-2 vaccine response in elderly people are mostly unknown. We studied individuals older than 60 and younger than 60 years, who had been vaccinated with SARS-CoV-2 BNT162b2 mRNA, before and after the first and second dose. Aging was associated with a lower anti-RBD IgG levels and a decreased magnitude and polyfunctionality of SARS-CoV-2-specific T cell response. The dramatic decrease in thymic function in people > 60 years, which fueled alteration in T cell homeostasis, and their lower CD161+ T cell levels were associated with decreased T cell response 2 months after vaccination. Additionally, deficient DC homing, activation, and TLR-mediated function, along with a proinflammatory functional profile in monocytes, were observed in the > 60-y</pubmed_abstract><journal>JCI insight</journal><pubmed_title>Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people.</pubmed_title><pmcid>PMC9536264</pmcid><funding_grant_id>DOC-00963</funding_grant_id><funding_grant_id>CV20-85418</funding_grant_id><funding_grant_id>FI19/00083</funding_grant_id><funding_grant_id>DOC-01659</funding_grant_id><funding_grant_id>PI19/01127</funding_grant_id><funding_grant_id>RH-0037-2020</funding_grant_id><funding_grant_id>CM20/00243</funding_grant_id><funding_grant_id>CP19/00159</funding_grant_id><funding_grant_id>FI17/00186</funding_grant_id><funding_grant_id>P20_00906</funding_grant_id><pubmed_authors>Rafii-El-Idrissi Benhnia M</pubmed_authors><pubmed_authors>Rivas-Jeremias I</pubmed_authors><pubmed_authors>Ruiz-Mateos E</pubmed_authors><pubmed_authors>Martin-Sanchez MA</pubmed_authors><pubmed_authors>Bachiller S</pubmed_authors><pubmed_authors>Silva-Sanchez MDM</pubmed_authors><pubmed_authors>Lopez-Cortes LF</pubmed_authors><pubmed_authors>Vitalle J</pubmed_authors><pubmed_authors>Gasca-Capote C</pubmed_authors><pubmed_authors>Jimenez-Leon MR</pubmed_authors><pubmed_authors>Ostos FJ</pubmed_authors><pubmed_authors>Ruiz-Mateos AM</pubmed_authors><pubmed_authors>Perez-Gomez A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people.</name><description>The immune factors associated with impaired SARS-CoV-2 vaccine response in elderly people are mostly unknown. We studied individuals older than 60 and younger than 60 years, who had been vaccinated with SARS-CoV-2 BNT162b2 mRNA, before and after the first and second dose. Aging was associated with a lower anti-RBD IgG levels and a decreased magnitude and polyfunctionality of SARS-CoV-2-specific T cell response. The dramatic decrease in thymic function in people > 60 years, which fueled alteration in T cell homeostasis, and their lower CD161+ T cell levels were associated with decreased T cell response 2 months after vaccination. Additionally, deficient DC homing, activation, and TLR-mediated function, along with a proinflammatory functional profile in monocytes, were observed in the > 60-y</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-18T20:59:50.15Z</modification><creation>2025-04-07T08:59:00.699Z</creation></dates><accession>S-EPMC9536264</accession><cross_references><pubmed>35943812</pubmed><doi>10.1172/jci.insight.161045</doi></cross_references></HashMap>